AI Drug Rentosertib: Lung Disease and Aging Reversal
This drug, initially designed to combat lung disease, has shown unexpected promise in reversing aging. Rentosertib, cra…
FDA Approves First Drug to Reverse Aging Genes
The FDA has authorized the first human trials for ER-100 a drug designed to reverse aging by targeting specific genes.…
Obesity Drug Market Set for 5x Growth by 2030, Reaching $77 Billion
The obesity drug market is anticipated to surge fivefold by 2030, reaching $77 billion, driven by escalating obesity ra…
Pharma R&D Investment: Oncology Leads Despite Heart Disease
Pharmaceutical research and development (R&D) investments are heavily concentrated in oncology, with nearly 10,000 drug…
PA-915: The Potential First Anti-Anxiety Vaccine
PA-915 is an experimental drug targeting the PAC1 receptor in the brain, showing promise in treating anxiety, stress, a…
IU1 Drug: Extending Human Life by 250 Years?
IU1, a drug developed by scientists at Osaka University, targets protein imbalance in cells, a key factor in aging and…
First Human Trials for Tooth Regrowth Drug
For the first time, a drug designed to stimulate tooth regrowth in humans has entered clinical trials. The drug targets…